2018 News Releases

2018 News Releases

Webcast ImageWebcast
Pacira Pharmaceuticals, Inc. at the BMO Capital Markets Conference Presentation (Live)
12/12/18 at 1:20 p.m. ET
Pacira Pharmaceuticals, Inc. at the BMO Capital Markets Conference Presentation
Wednesday, December 12, 2018 1:20 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Pacira Pharmaceuticals to Present at the 2018 BMO Capital Markets Prescriptions for Success Healthcare Conference
12/07/18
New Data Show EXPAREL Plays a Key Role in Achieving Significant Reductions in Opioid Use, Hospital Stay and Total Hospitalization Costs Following Painful Knee Replacement Surgery
11/27/18
Pacira Pharmaceuticals CMO Presents at FDA Advisory Committee Meeting Focused on Assessment of Opioid-Sparing Outcomes in Clinical Trials
11/16/18
Pacira Pharmaceuticals to Present at Healthcare Conferences in November
11/08/18
Centers for Medicare and Medicaid Services and American Dental Association Establish New Reimbursement for EXPAREL
11/02/18
Pacira Pharmaceuticals, Inc. Reports Third Quarter 2018 Financial Results
11/01/18
Aetna Offers Expanded Coverage for EXPAREL® in Select Ambulatory Surgical Centers 
10/30/18
Pacira to Report Third Quarter 2018 Financial Results on Thursday November 1, 2018
10/25/18
New Research Reveals Potency and Quantity of Opioids Prescribed for Postsurgical Pain Poses Danger to Patients, their Families and Friends
10/11/18
Pacira Pharmaceuticals to Present at the 2018 Wedbush Pacgrow Healthcare Conference
08/08/18
Pacira Pharmaceuticals, Inc. Reports Second Quarter 2018 Financial Results
08/02/18
Pacira to Report Second Quarter 2018 Financial Results on Thursday August 2, 2018
07/25/18
Pacira Reports Preliminary Net EXPAREL® Sales of $80.4 Million for Second Quarter of 2018
07/10/18
Pacira Pharmaceuticals and Nuance Biotech Announce License Agreement for EXPAREL® in China
06/19/18
Aetna DocFind Directory Now Highlights Providers Offering Opioid Alternatives, Including EXPAREL®
06/15/18
MEDNAX National Medical Group and Pacira Pharmaceuticals Launch National Enhanced Recovery after Cesarean Surgery (ERACS™) Collaborative to Minimize Opioid Use
06/13/18
Pacira Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
05/31/18
Pacira Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results
05/03/18
Pacira Pharmaceuticals to Present at Two Healthcare Conferences in May
05/01/18
Pacira Pharmaceuticals Announces Timing for First Quarter 2018 Financial Results Webcast and Conference Call
04/26/18
Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® as a Nerve Block to Produce Regional Analgesia
04/06/18
Pacira Pharmaceuticals to Present at the 2018 Barclays Global Healthcare Conference
03/06/18
Pacira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
02/28/18
University of Tennessee Medical Center at Knoxville, Pacira Pharmaceuticals, and CQ-Insights Announce Collaboration to Minimize Opioid Use After Hernia Surgery
02/27/18
Pacira Pharmaceuticals Announces Timing for 2017 Financial Results Webcast and Conference Call
02/22/18
Pacira Pharmaceuticals to Present at the 2018 RBC Capital Markets Healthcare Conference
02/16/18
Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional Analgesia
02/15/18
Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
02/14/18
FDA Posts Briefing Documents for Advisory Meeting Reviewing sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
02/12/18
WellStar Health System and Pacira Pharmaceuticals Announce Partnership to Minimize Opioid Use and Standardize Outcomes Across Surgical Procedures
01/08/18
Pacira Pharmaceuticals Reports Preliminary 2017 Revenues of $286.6 Million
01/04/18
Pacira Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference
01/03/18